UBS lowered the firm’s price target on Universal Health (UHS) to $310 from $320 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Spotify upgraded, Alibaba initiated: Wall Street’s top analyst calls
- Universal Health price target lowered to $194 from $229 at Cantor Fitzgerald
- Universal Health price target lowered to $230 from $245 at TD Cowen
- Universal Health price target lowered to $211 from $238 at Guggenheim
- Universal Health price target lowered to $190 from $216 at RBC Capital